Cargando…
Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used in the treatment of EGFR mutation non-small-cell lung cancer. The Chinese government has made great efforts to improve the availability and affordability of these drugs. The aim of this study...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973903/ https://www.ncbi.nlm.nih.gov/pubmed/35365136 http://dx.doi.org/10.1186/s12913-022-07868-9 |